Stacy Pryts

Title: Innovations by Stacy Pryts in Biotherapeutics

Introduction

Stacy Pryts is an accomplished inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biotherapeutics, particularly in the development of binding proteins that target critical immune checkpoints.

Latest Patents

Stacy Pryts holds a patent for "Bispecific PD-1 and TIGIT binding proteins and uses thereof." This patent relates to binding proteins, including antibodies, that specifically bind to Programmed Death-1 (PD-1) and T cell immunoreceptor with Ig and ITIM domains (TIGIT). The patent also encompasses compositions comprising such binding proteins and nucleic acid molecules encoding them. Furthermore, it details methods for treating various disorders or conditions using these innovative binding proteins.

Career Highlights

Stacy is currently employed at MedImmune Limited, where she continues to advance her research in immunotherapy. Her work has the potential to impact the treatment of various diseases by enhancing the immune response against tumors.

Collaborations

Stacy collaborates with notable colleagues, including Yariv Mazor and Yue Wang, who contribute to her research efforts and the development of new therapeutic strategies.

Conclusion

Stacy Pryts exemplifies the innovative spirit in the field of biotherapeutics, with her groundbreaking patent and ongoing work at MedImmune Limited. Her contributions are paving the way for new treatments that could significantly improve patient outcomes.